Latest Articles

Publication Date
‘Actress Amy Schumer, 44, Recent Colonoscopy Helps Reduce Cancer Risks By Wiping Out Precancerous Polyps Proactively, But She Says Her Procedure Left Her Recovering Longer Than Expected - SurvivorNet

‘Actress Amy Schumer, 44, Recent Colonoscopy Helps Reduce Cancer Risks By Wiping Out Precancerous Polyps Proactively, But She Says Her Procedure Left Her Recovering Longer Than Expected SurvivorNet

Published: May 19, 2026, 9:40 p.m.
Pfizer Takes Aim at Merck in New Phase 3 Endometrial Cancer Trial - TipRanks

Pfizer Takes Aim at Merck in New Phase 3 Endometrial Cancer Trial TipRanks

Published: May 19, 2026, 4:44 p.m.
Merck's ADC Candidate Meets Goals in Endometrial Cancer Study - Yahoo Finance

Merck's ADC Candidate Meets Goals in Endometrial Cancer Study Yahoo Finance

Published: May 19, 2026, 3:47 p.m.
GLP-1s May Help Reduce Endometrial Cancer Risk in Patients With Obesity and Metabolic Disease - Pharmacy Times

GLP-1s May Help Reduce Endometrial Cancer Risk in Patients With Obesity and Metabolic Disease Pharmacy Times

Published: May 19, 2026, 3:15 p.m.
KPTI: SENTRY and ECO42 trials highlight selinexor's promise in myelofibrosis and endometrial cancer - TradingView

KPTI: SENTRY and ECO42 trials highlight selinexor's promise in myelofibrosis and endometrial cancer TradingView

Published: May 19, 2026, 2 p.m.
Merck’s billion-dollar Kelun bet pays off as TROP2 improves survival in endometrial cancer - BioSpace

Merck’s billion-dollar Kelun bet pays off as TROP2 improves survival in endometrial cancer BioSpace

Published: May 19, 2026, 11:19 a.m.
Merck reports breakthrough Phase 3 win for sac-TMT in endometrial cancer - Indian Pharma Post

Merck reports breakthrough Phase 3 win for sac-TMT in endometrial cancer Indian Pharma Post

Published: May 19, 2026, 9:08 a.m.
Merck-Kelun ADC boosts survival in phase 3 endometrial cancer, stokes TROP2 race - CHOSUNBIZ - Chosunbiz

Merck-Kelun ADC boosts survival in phase 3 endometrial cancer, stokes TROP2 race - CHOSUNBIZ Chosunbiz

Published: May 19, 2026, 6:54 a.m.
Merck's Sac-TMT Shows Promise in Advanced Endometrial Cancer Tri - GuruFocus

Merck's Sac-TMT Shows Promise in Advanced Endometrial Cancer Tri GuruFocus

Published: May 18, 2026, 11:38 p.m.
Merck (MRK) Achieves Milestone in Endometrial Cancer Treatment T - GuruFocus

Merck (MRK) Achieves Milestone in Endometrial Cancer Treatment T GuruFocus

Published: May 18, 2026, 10:39 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!